Aflibercept 3.6mg/90microlitres solution for injection pre-filled syringes
NHS hospitals in England used £246,962,776 of indicative cost of Aflibercept 3.6mg/90microlitres solution for injection pre-filled syringes in the 12 months to July 2026, about 0.9% of all hospital medicines spend. That is down 45.3% on the previous 12 months.
Indicative cost · 12 months
Quantity (VMP units) · 12 months
Share of hospital medicines spend
Figure 1. Aflibercept 3.6mg/90microlitres solution for injection pre-filled syringes: NHS hospital indicative cost by month (£ millions)
Source: NHSBSA Secondary Care Medicines Data, to July 2026
Cost is indicative — actual hospital medicine prices are commercially confidential, so these figures are estimated from list prices. See methodology.
NHS trusts using Aflibercept 3.6mg/90microlitres solution for injection pre-filled syringes most
By indicative cost over the 12 months to July 2026.
| NHS trust | Indicative cost (12 months) |
|---|---|
| Moorfields Eye Hospital Nhs Ft | £15,510,486 |
| South Tees Hosp Nhs Foundation Trust | £10,772,850 |
| Derby Teaching Hospitals Nhs Found Trust | £7,829,210 |
| Shrewsbury & Telford Hospital Nhs Trust | £7,522,738 |
| York Teaching Hospital Nhs Ft | £6,809,164 |
| Sheffield Teaching Hospitals Nhs Trust | £5,665,316 |
| Hull And East Yorkshire Hpls Nhs Trust | £5,345,074 |
| King's College Hpl Nhs Foundation Trust | £5,255,894 |
| Sherwood Forest Hospitals Nhs Trust | £5,066,902 |
| South Tyneside And Sunderland Nhs Ft | £4,862,014 |
The primary-care picture
No confident match to a community-dispensed medicine was found for this product, so no primary-care comparison is shown. SCMD products are recorded at product level, which does not always map cleanly to a BNF substance.